Akadeum at Advanced Therapies Week 2025 in Dallas
Event Start Date: 01/20/2025 Share
Akadeum Announces Alerion™ Microbubble Cell Separation System Availability
After a year of testing onsite with therapeutic developers, Akadeum Life Sciences, a leader in cell separation, is excited to announce the opportunity for the scientific community to purchase the Alerion™ Microbubble Cell Separation System for use in research through clinical settings. Confirmed by customers to be the highest capacity, fastest, most gentle cell isolation system ever built, the successful Alerion™ early access program resulted in requests to purchase the systems, accelerating much needed improvements in the cell therapy manufacturing space.
Akadeum will be attending Advanced Therapies Week 2025, held at the Kay Bailey Hutchinson Convention Center in Dallas, TX, from January 20-23, 2025, and will host numerous opportunities for those interested to learn more about the Alerion™.
Finalist for Tech Disruptor of the Year Award
Driven by the performance of the Alerion™ and microbubble technology in the early access program, Akadeum is honored to be considered amongst the finalists of this prestigious award. The Technology Distributor of the Year Award recognizes exceptional technological innovation in cell and gene therapy, and is awarded to organizations who have significantly advanced the industry with new technologies.
Members of the team will be in attendance at the awards ceremony.
Acquire an Alerion™ – Visit Booth #735
Attendees are invited to visit Booth #735 to learn more about how they can acquire the Alerion™ Microbubble Cell Separation System, the highest capacity, fastest and most gentle cell separation system ever. The Alerion™ System enables cell therapy workflows via isolation of healthier cells, which are critical for development of better therapies. Experts from our team will be available to discuss how these solutions are accelerating and enabling the future of cell therapy development and manufacturing.
See Alerion™ Data at Our Presentation
Akadeum’s Senior Director of Research and Development, Dr. Bill Lloyd, will deliver an in-depth presentation titled: “Improving CAR-T Therapy Workflows with Microbubbles: Fast, Large Scale Cell Isolation for Healthier Cells”, on Thursday, January 23, at 9:00 AM. Join us to see data from the Alerion™ beta and early access programs, which consisted of participation from five cell therapy developers and five CDMOs.
About Akadeum Life Sciences
Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the Alerion™ Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material in under an hour, significantly expanding capacity of manufacturers.
Akadeum is currently working with some of the largest corporations and forward-thinking leaders in the industry. The power of the Akadeum microbubble platform is an elegant and easy-to-use technology that can enable faster, more accurate, and scalable workflows to improve human health.
About Phacilitate and Advanced Therapies Week
For over 20 years, industry leaders Phacilitate have been at the forefront of organizing this flagship event, a premier event of innovation and collaboration in cell and gene therapy. With key stakeholders, innovators, and decision-makers all in attendance, connections are made that can transform the cell and gene therapy space and propel initiatives forward.